EpicentRx
PrivateLast Round
Grant
Sep 17, 2024
Total Funding Raised
$47.31M
Company Overview
EpicentRx operates in Healthcare & Life Sciences and is based in La Jolla, California. Its latest recorded funding round was a Grant round in September 2024.
EpicentRx is a biotechnology company that develops a next-generation immunotherapy platform and small molecule therapies to treat cancer, inflammatory diseases, and other conditions with unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpicentRx Comparables
Compare EpicentRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TILT Biotherapeutics | 81% | |
| BioEclipse Therapeutics | 79% | |
| Lokon Pharma | 79% |
For institutional investors. Book with your work email.
EpicentRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 17, 2024 | ||||
| Grant | Nov 29, 2022 | ||||
| Grant | Jul 12, 2022 | ||||
| Debt | Jan 6, 2021 | ||||
| Series D | Nov 14, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EpicentRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FightMND | Grant |
| Shake it Up Australia Foundation | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Silicon Valley Bank | Debt |
EpicentRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EpicentRx's valuation, stock price, and market status.
Is EpicentRx a public or private company?
EpicentRx is a private company.
What is the current stock price of EpicentRx?
EpicentRx is a private company, so its shares have no public market price. Caplight tracks EpicentRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EpicentRx worth (valuation)?
Valuation information for EpicentRx is not publicly available.
Can I buy EpicentRx stock?
EpicentRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EpicentRx's last funding round?
EpicentRx's most recent funding round was Grant on September 17, 2024.
Who are the main investors in EpicentRx?
Key investors in EpicentRx include FightMND, The Michael J. Fox Foundation for Parkinson's Research, Congressionally Directed Medical Research Programs, Silicon Valley Bank.
Will EpicentRx IPO soon?
No public IPO plans have been announced for EpicentRx.
How can I track EpicentRx secondary market activity?
Caplight tracks bids, offers, and trades in EpicentRx's shares on secondary markets.